Ionis Pharmaceuticals's total assets for Q4 2024 were $3.00B, a decrease of -2.51% from the previous quarter. IONS total liabilities were $2.42B for the fiscal quarter, a -0.14% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.